ArticleJournal of clinical medicine research2019

Renoprotective Benefit of Tolvaptan in Acute Decompensated Heart Failure Patients With Loop Diuretic-Resistant Status.

Tomohiko Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.